IMB-301 is primarily used in the field of biomedical research, particularly in the study of cancer therapies. It functions as a small molecule inhibitor that targets specific pathways involved in tumor growth and survival. Researchers utilize IMB-301 to investigate its potential in suppressing cancer cell proliferation and inducing apoptosis in various cancer models. Its application extends to preclinical studies where it is tested for efficacy and safety in combination with other therapeutic agents. Additionally, IMB-301 is employed in molecular biology experiments to better understand cellular signaling mechanisms and to identify potential biomarkers for cancer treatment. This compound plays a crucial role in advancing the development of targeted cancer therapies and improving patient outcomes.